274 related articles for article (PubMed ID: 22675565)
21. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
[TBL] [Abstract][Full Text] [Related]
23. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
[TBL] [Abstract][Full Text] [Related]
24. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma.
Yoo NJ; Kim YR; Lee SH
Acta Oncol; 2012 Jan; 51(1):107-11. PubMed ID: 21736506
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
28. A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells.
Spinella JF; Cassart P; Garnier N; Rousseau P; Drullion C; Richer C; Ouimet M; Saillour V; Healy J; Autexier C; Sinnett D
BMC Cancer; 2015 Sep; 15():621. PubMed ID: 26345285
[TBL] [Abstract][Full Text] [Related]
29. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
[TBL] [Abstract][Full Text] [Related]
30. Dual Deep Sequencing Improves the Accuracy of Low-Frequency Somatic Mutation Detection in Cancer Gene Panel Testing.
Ura H; Togi S; Niida Y
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429412
[TBL] [Abstract][Full Text] [Related]
31. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
[TBL] [Abstract][Full Text] [Related]
32. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
33. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
34. Cost-effective screening of DNMT3A coding sequence identifies somatic mutation in pediatric T-cell acute lymphoblastic leukemia.
Szarzyńska-Zawadzka B; Kosmalska M; Sędek Ł; Sonsala A; Twardoch M; Kowalczyk JR; Szczepański T; Witt M; Dawidowska M
Eur J Haematol; 2017 Dec; 99(6):514-519. PubMed ID: 28905428
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Baldus CD; Thibaut J; Goekbuget N; Stroux A; Schlee C; Mossner M; Burmeister T; Schwartz S; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
Haematologica; 2009 Oct; 94(10):1383-90. PubMed ID: 19794083
[TBL] [Abstract][Full Text] [Related]
36. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Zuurbier L; Petricoin EF; Vuerhard MJ; Calvert V; Kooi C; Buijs-Gladdines JG; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2012 Sep; 97(9):1405-13. PubMed ID: 22491738
[TBL] [Abstract][Full Text] [Related]
37. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
Nachmanson D; Steward J; Yao H; Officer A; Jeong E; O'Keefe TJ; Hasteh F; Jepsen K; Hirst GL; Esserman LJ; Borowsky AD; Harismendy O
BMC Med Genomics; 2020 Nov; 13(1):173. PubMed ID: 33208147
[TBL] [Abstract][Full Text] [Related]
38. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
[TBL] [Abstract][Full Text] [Related]
40. Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Giménez-Capitán A; Bracht J; García JJ; Jordana-Ariza N; García B; Garzón M; Mayo-de-Las-Casas C; Viteri-Ramirez S; Martinez-Bueno A; Aguilar A; Sullivan IG; Johnson E; Huang CY; Gerlach JL; Warren S; Beechem JM; Teixidó C; Rosell R; Reguart N; Molina-Vila MA
Clin Chem; 2021 Mar; 67(3):554-563. PubMed ID: 33439966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
